Healthcare refers to the maintenance and improvement of health through the prevention, diagnosis, treatment, and recovery from illness, injuries, and other physical or mental conditions. It encompasses a broad range of services, including medical, preventive, therapeutic, and supportive measures provided by healthcare professionals, institutions, and systems. We are using technological innovation to make healthcare better and safer.

Posts

Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists’ Visual Estimates

The development of next-generation sequencing (NGS) has enabled the discovery of cancer-specific driver gene alternations, making precision medicine possible. However, accurategenetic testing requires a sufficient amount of tumor cells in the specimen. The evaluation of tumor content ratio (TCR) from hematoxylin and eosin (H&E)-stained images has been found to vary between pathologists, making it an important challenge to obtain an accurate TCR. In this study, three pathologists exhaustively labeled all cells in 41 regions from 41 lung cancer cases as either tumor, non-tumor or indistinguishable, thus establishing a “gold standard” TCR. We then compared the accuracy of the TCR estimated by 13 pathologists based on visual assessment and the TCR calculated by an AI model that we have developed. It is a compact and fast model that follows a fully convolutional neural network architecture and produces cell detection maps which can be efficiently post-processed to obtain tumor and non-tumor cell counts from which TCR is calculated. Its raw cell detection accuracy is 92% while its classification accuracy is 84%. The results show that the error between the gold standard TCR and the AI calculation was significantly smaller than that between the gold standard TCR and the pathologist’s visual assessment (p < 0.05). Additionally, the robustness of AI models across institutions is a key issue and we demonstrate that the variation in AI was smallerthan that in the average of pathologists when evaluated by institution. These findings suggest that the accuracy of tumor cellularity assessments in clinical workflows is significantly improved by the introduction of robust AI models, leading to more efficient genetic testing and ultimately to better patient outcomes.

Hierarchical Imitation Learning with Contextual Bandits for Dynamic Treatment Regimes

Imitation learning has been proved to be effective in mimicking experts’ behaviors from their demonstrations without access to explicit reward signals. Meanwhile, complex tasks, e.g., dynamic treatment regimes for patients with comorbidities, often suggest significant variability in expert demonstrations with multiple sub-tasks. In these cases, it could be difficult to use a single flat policy to handle tasks of hierarchical structures. In this paper, we propose the hierarchical imitation learning model, HIL, to jointly learn latent high-level policies and sub-policies (for individual sub-tasks) from expert demonstrations without prior knowledge. First, HIL learns sub-policies by imitating expert trajectories with the sub-task switching guidance from high-level policies. Second, HIL collects the feedback from its sub-policies to optimize high-level policies, which is modeled as a contextual multi-arm bandit that sequentially selects the best sub-policies at each time step based on the contextual information derived from demonstrations. Compared with state-of-the-art baselines on real-world medical data, HIL improves the likelihood of patient survival and provides better dynamic treatment regimes with the exploitation of hierarchical structures in expert demonstrations.